Myriad Genetics, Inc. is a leader in genetic testing and precision medicine, offering genetic tests that help assess the risk of developing disease or disease progression, guiding treatment decisions across medical specialties, and advancing health and well-being for all. Its oncology portfolio includes hereditary cancer and companion diagnostic testing options.